Drugs associated with ischemic stroke: a review for clinicians

João Pedro Marto*, Davide Strambo, Francoise Livio, Patrik Michel

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

30 Citations (Scopus)

Abstract

Certain drugs may increase the risk of ischemic stroke (IS). Our goal was to review associations between frequently used drugs and IS. We created an initial list of frequently used drugs to search Pubmed/MEDLINE from 1966 to 2020 and reviewed phase III and IV data, case series, and drug authorities' safety warnings to assess a potential association with IS. Drugs were grouped according to the World Health Organization Anatomical Therapeutic Chemical Classification System. Predefined criteria were applied to establish a level of evidence for an association, from A (high level of evidence of association) to E (high level of evidence of absence of association). In addition, we assessed relative risks and reviewed potential mechanisms of IS facilitation. We assessed 81 drugs or drug classes from 11 World Health Organization Anatomical Therapeutic Chemical Groups. We identified a high level of association for erythropoietin, combined contraceptives, oral estrogen replacement therapy, bevacizumab, tamoxifen, and antipsychotics and a moderate level for ponatinib, nilotinib, darunavir, and gonadotropin-releasing hormone agonists. Drug dose and treatment duration may modify the risk. For a substantial number of drugs, we found no association, and for others, there were insufficient data to categorize risk. We identified a high level of association of IS with a limited number of drugs, a potential association with some, and a lack of data for others. The summarized information may help clinicians to estimate the contribution of a drug to an IS, to better assess drug benefit-risk ratios, and to support decisions about using specific drugs.

Original languageEnglish
Pages (from-to)E646-E659
Number of pages14
JournalStroke
Volume52
Issue number10
DOIs
Publication statusPublished - 1 Oct 2021
Externally publishedYes

Keywords

  • Adverse drug event
  • Drugs
  • Ischemic stroke
  • Odds ratio
  • Prescription drugs
  • Risk

Fingerprint

Dive into the research topics of 'Drugs associated with ischemic stroke: a review for clinicians'. Together they form a unique fingerprint.

Cite this